Peptides DB

Research-centric peptide and protocol reference hub

BPC-157 vs Hexarelin

Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team

BPC-157: Research use — not FDA-approvedHexarelin: Research use — not FDA-approved

A data-driven comparison of BPC-157 and Hexarelin (also searched as Hexarelin vs BPC-157) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

BPC-157 centers on healing, while Hexarelin leans toward muscle. On indexed research, BPC-157 is ahead (BPC-157: 6 studies, Human evidence; Hexarelin: 4, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • BPC-157 is strongest for healing; Hexarelin for muscle.
  • Evidence: BPC-157 Human evidence (6 studies) vs Hexarelin Human evidence (4).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

HealingMuscleMetabolicNeuroSleepInflammationSkin
BPC-157Hexarelin

At a glance

BPC-157Human evidence

Body Protection Compound-157 | Pentadecapeptide

Strongest: HealingStudies: 6Level: Extensively Studied
HexarelinHuman evidence

Examorelin | Synthetic Growth Hormone Secretagogue

Strongest: MuscleStudies: 4Level: Well Studied

BPC-157 vs Hexarelin: side-by-side

MetricBPC-157Hexarelin
ClassHealingGH
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed64
Research levelExtensively StudiedWell Studied
Strongest effectHealing & recoveryMuscle & body comp
Healing & recovery4.31.0
Muscle & body comp3.34.0
Metabolic & appetite2.33.0
Neuro & mood3.02.0
Sleep & circadian0.71.0
Inflammation & immune4.02.0
Skin & aesthetics2.03.0

▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).

Mechanism & pharmacokinetics

PropertyBPC-157Hexarelin
MechanismBody-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signaling
RouteSubcutaneous / oral (research use)

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is BPC-157?

Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.

Full BPC-157 profile, mechanism & studies →

What is Hexarelin?

### Hexarelin Summary Hexarelin is a synthetic hexapeptide that belongs to the growth hormone secretagogue (GHS) class, known for its ability to stimulate growth hormone release from the pituitary gland. It has been investigated for its potential therapeutic applications in various conditions, including muscle wasting and age-related decline in growth hormone levels.

Full Hexarelin profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingBPC-1574.3/5 effect signal
MuscleHexarelin4.0/5 effect signal
MetabolicHexarelin3.0/5 effect signal
NeuroBPC-1573.0/5 effect signal
SleepHexarelin1.0/5 effect signal
InflammationBPC-1574.0/5 effect signal
SkinHexarelin3.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack BPC-157 and Hexarelin?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

BPC-157 vs Hexarelin: side effects

BPC-157
  • improved healing28
  • flushing14
  • vivid dreams11
  • nausea3
  • anxiety2
Hexarelin

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

BPC-157 has 6 approved studies indexed (Human evidence), and Hexarelin has 4 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is BPC-157 or Hexarelin better?

It depends on your goal. BPC-157 is strongest for healing; Hexarelin for muscle. BPC-157 has more indexed studies (6). See the goal-by-goal breakdown above.

Is BPC-157 or Hexarelin better for weight loss?

Hexarelin shows the stronger metabolic & appetite profile (3.0/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.

Is BPC-157 or Hexarelin better for muscle?

Hexarelin leads on the muscle & body-composition axis (4.0/5).

Which has more research, BPC-157 or Hexarelin?

BPC-157 has 6 approved studies indexed (Human evidence); Hexarelin has 4 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack BPC-157 and Hexarelin?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of BPC-157 vs Hexarelin?

BPC-157: community-reported improved healing, flushing, vivid dreams. Hexarelin: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is BPC-157 or Hexarelin FDA-approved?

BPC-157 is a research-use compound and is not FDA-approved. Hexarelin is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is Hexarelin better than BPC-157?

For muscle, Hexarelin has the edge; for healing, BPC-157 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

BPC-157 and Hexarelin are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.